News
The North Carolina Seqirus Factory Gets A $156mn Upgrade
Seqirus recently completed a $156 million expansion plan at its Holly Springs, North Carolina, fill-finish production plant, which began in 2018. The expanded facility,...
News
GARDP And Bugworks Evaluate The New Antibiotic Tolerability
The Global Antibiotic Research and Development Partnership- GARDP and Bugworks are working together on research to determine the safety profile of a novel class of broad-spectrum...
News
GSK Unveils New Logo, Branding To Mirror Improved Business
The British Big Pharma has launched an innovative rebranding, a tech-flavoured logo, and an impactful transformation for the future as GlaxoSmithKline turns GSK and...
News
Amarin Wins Vazkepa In U.K Days After US Downsizing Plan
Amarin has earned a much-needed triumph internationally after faltering in the crucial US market. Vazkepa has been approved by the National Institute for Health...
News
Teva Post Lupin Deal To Launch Austedo Generic Rival In 2033
Teva can rest easy knowing that it does have a long runway free of generics—at least from two major challengers—as it focuses on the...
News
Fibrogen-Astellas Anaemia Drug Evrenzo Gets NICE Backing
Despite a high-profile FDA denial, FibroGen and its collaborators have been able to expand into new markets outside of the United States with Evrenzo,...
News
Drug Launch Prices Have Gone Up 20% Yearly For A Decade
As many Americans face difficult financial decisions thanks to inflation, a new study verifies what many have feared for years: drug prices are significantly...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read